Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients Journal of Human Hypertension advance online publication, June 26 2014. doi:10.1038/jhh.2014.43 Authors: L P Hasvold, J Bodegård, M Thuresson, J Stålhammar, N Hammar, J Sundström, D Russell & S E Kjeldsen

http://feeds.nature.com/~r/jhh/rss/aop/~3/y0c4xmgt0aA/jhh.2014.43

Source: Journal of Human Hypertension - June 26, 2014 Category: Cardiology Authors: L P HasvoldJ BodegårdM ThuressonJ StålhammarN HammarJ SundströmD RussellS E Kjeldsen Source Type: research

More News: Cardiology | Diabetes | Endocrinology | Hypertension | Study